[CLINICAL TRIAL WITH ACTOMOL (A-METHYLBENZYLHYDRAZINE) DURING A 1-YEAR PERIOD IN RELATION TO THE CESSATION OF DEPRESSION. PRELIMINARY REPORT].
D003863:Depression; D003866:Depressive Disorder; D004358:Drug Therapy; D006801:Humans; D006834:Hydrazines; D001523:Mental Disorders; D008996:Monoamine Oxidase Inhibitors
D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; C004343:mebanazine
DEPRESSION; DRUG THERAPY; HYDRAZINES; MENTAL DISORDERS; MONOAMINE OXIDASE INHIBITORS
KLINISKA FOERSOEK MED ACTOMOL (A-METYLBENZYLHYDRAZIN) UNDER 1 ARS TID I SAMBAND MED DEPRESSIONSTILLSTAND. PRELIMINAERRAPPORT.